IRBM Signs Collaboration Agreement with Merck & Co.

Published on: 

Applied Clinical Trials

IRBM, announced a new agreement in the peptide therapeutics area with Merck & Co. Inc., Kenilworth NJ USA, continuing their long-standing history of collaboration that began in 2010. This new agreement is focused on advancing peptide therapeutics.

Read the full release here.